<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1649">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379297</url>
  </required_header>
  <id_info>
    <org_study_id>CNER 202004/01</org_study_id>
    <secondary_id>831x6ce0d</secondary_id>
    <secondary_id>FNR/CON-VINCE</secondary_id>
    <nct_id>NCT04379297</nct_id>
  </id_info>
  <brief_title>COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)</brief_title>
  <acronym>CON-VINCE</acronym>
  <official_title>COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luxembourg Institute of Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Luxembourg National Research Funds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Luxembourg/ Luxembourg Centre for Systems Biomedicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier du Luxembourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TNS-Ilres</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratoires Réunis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BioneXt Lab</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ketterthill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratoire National de santé</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Luxembourg Institute of Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CON-VINCE (COvid-19 National survey for assessing VIral spread by Non-affected CarriErs) is a&#xD;
      national, monocentric, and longitudinal study aiming to evaluate the spread dynamics of the&#xD;
      COVID-19 disease within the Luxembourgish population. Participants who are clinically&#xD;
      asymptomatic or present with only mild symptoms will be followed up longitudinally, regularly&#xD;
      tested for SARS-CoV-2 by RT-PCR, antibody status, and subjected to an epidemiological,&#xD;
      clinical and biological phenotyping to better understand the nature, dynamics of infectivity&#xD;
      and spread of the virus in the population. CON-VINCE will also track the psychological and&#xD;
      socio-economic impact of long-term containment measures on the general population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To capture the dynamics and impact of the virus spread in the Luxembourgish population, data&#xD;
      and sample collection is done every two weeks for two months (4 times in total) with a final&#xD;
      follow-up one year after the participant's inclusion in the study. Participants complete&#xD;
      questionnaires before each sample collection. The baseline questionnaire captures demographic&#xD;
      data, medical history, behavioral and psychological data, and socio-economic status.&#xD;
      Participants provided information on medical history, history of allergies, smoking, and&#xD;
      chronic medication taken regularly. COVID-19-related data and environmental conditions of the&#xD;
      household were obtained.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 10, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence and dynamics of the SARS-COV 2 infection in Luxemburg</measure>
    <time_frame>04.2020-05.2021</time_frame>
    <description>Evaluation of the prevalence by RT-PCR and serology testing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Collection of samples for research</measure>
    <time_frame>04.2020-05.2021</time_frame>
    <description>Samples will be analysed and stored for future research</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psycho-social evaluation</measure>
    <time_frame>04.2020-05.2021</time_frame>
    <description>Psychological and socio- economic impact of long-term containment measures on the general population</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>COVID19</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Naso-pharyngeal swab, Oro-pharyngeal swab, Blood, sputum,Stool&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Representative panel of the Luxembourgish population&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects aged 18 and older of both genders, with a full capacity of consent.&#xD;
&#xD;
          -  SARS-CoV-2-positive individuals with an asymptomatic or oligosymptomatic infection&#xD;
             (mild or oligosymptomatic disease course is defined as absence of fever and&#xD;
             respiratory distress or cough not attributable to other known chronic disease).&#xD;
&#xD;
          -  OR SARS-CoV-2-negative individuals at the time of inclusion.&#xD;
&#xD;
          -  OR post-infectious SARS-CoV-2-negative individuals with acquired immunity to&#xD;
             SARS-CoV-2 and a mild disease course.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Evolution of the COVID-19 disease requiring a hospital admission before inclusion in&#xD;
             the study&#xD;
&#xD;
          -  Presence of fever and respiratory distress/cough at the time of inclusion not&#xD;
             attributable to other known chronic disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rejko Krüger, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Luxembourg Institute of Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Luxembourg Institute of Health</name>
      <address>
        <city>Strassen</city>
        <zip>1445</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Luxembourg</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronavirus</keyword>
  <keyword>COVID</keyword>
  <keyword>Prevalence</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

